In-licensing Opportunities
Value-Added Medicines to Expand your Portfolio
Looking for new and affordable revenue opportunities?
We’ve developed the following cost-effective and quick-to-market products specifically for in-licensing.
We’re now seeking partners to bring them to new markets.
TrazoFlex™ Tablets
Breakable 300mg and 150mg once-daily trazodone tablets for Major Depressive Disorder allows smooth start low-go slow titration from 7 75mg to 375mg. Effective from the first week of treatment and with efficacy for improved sleep without weight gain or other SSRI type drawbacks, TrazoFlex tablets may also benefit patients with comorbidities such as fibromyalgia, diabetic neuropathy, bulimia and benzodiazepine or alcohol abuse.
DeslaFlex™ Tablets
Breakable 100mg and 50mg once-daily desvenlafaxine tablets for Major Depressive Disorder allows up and down precision dosing from 25mg to 200mg. DeslaFlex tablets may also provide value for patients with neuropathic pain, generalized anxiety, social anxiety disorder, panic attacks or hot flashes.
NeuroFlex™ Tablets
Breakable NeuroFlex pregabalin XR tablets offer more dosage strengths from a minimum number of tablets for simple and cost-effective titration. NeuroFlex also enables the “low and slow” titration approach preferred by prescribers to better manage symptoms vs side-effects and keep patients adherent to treatment, a key component of managing neuropathic pain.
Breakable quetiapine XR tablets provide flexible and once-daily dosing to
simplify titration and high-dose adjustments from a minimum number of prescriptions, improving both compliance and patient experiences.